Novel Inflammasome Targets Relevant To Alzheimer’s Disease

Time: 2:00 pm
day: Day 2 - Track B - Afternoon


  • Alzheimer’s disease is a disease of both proteinopathy and immunopathy
  • New therapeutic directions affecting the innate immune system, especially targets that impact on microgliamediated inflammation
  • Case studies in two areas of drug discovery at our Institute